Alphabet is already a leader in AI and boasts attractive growth avenues beyond this industry. Recursion Pharmaceuticals has a long way to go before demonstrating that its approach works. 10 stocks we ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

XOMA Royalty Corporation (XOMA) on Tuesday announced that it reached a new royalty sharing transaction with Takeda (TAK) and amended its existing royalty sharing agreement for the Japanese drugmaker’s ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Maya Higa’s Alveus Sanctuary has reached its $1 million donation goal to fund the creation of the Alveus Research & Recovery Institute, a new project focused on wildlife conservation and species ...

Community driven content discussing all aspects of software development from DevOps to design patterns. The speed and efficiency of traditionally developed software applications is limited by the fact ...